--- title: "Novo Nordisk's U.S. stock pre-market surged nearly 7%. In terms of news, the company's weight loss d" description: "Novo Nordisk's U.S. stock pre-market surged nearly 7%. In terms of news, the company's weight loss drug oral Wegovy's Phase III clinical trial achieved positive results, with patients averaging a weig" type: "news" locale: "en" url: "https://longbridge.com/en/news/257878592.md" published_at: "2025-09-18T09:35:06.000Z" --- # Novo Nordisk's U.S. stock pre-market surged nearly 7%. In terms of news, the company's weight loss d > Novo Nordisk's U.S. stock pre-market surged nearly 7%. In terms of news, the company's weight loss drug oral Wegovy's Phase III clinical trial achieved positive results, with patients averaging a weight loss of 16.6% Novo Nordisk's U.S. stock pre-market surged nearly 7%. In terms of news, the company's weight loss drug oral Wegovy's Phase III clinical trial achieved positive results, with patients averaging a weight loss of 16.6% ### Related Stocks - [NVO.US - Novo Nordisk AS](https://longbridge.com/en/quote/NVO.US.md) ## Related News & Research | Title | Description | URL | |-------|-------------|-----| | Novo Nordisk CFO Karsten Munk Knudsen Sells Shares Worth Over DKK 8.3 Million | Novo Nordisk A/S announced that CFO Karsten Munk Knudsen sold 26,246 shares for DKK 8.3 million at DKK 315.60 each and 3 | [Link](https://longbridge.com/en/news/275652909.md) | | Berenberg Bank Reaffirms Their Buy Rating on Novo Nordisk (0QIU) | Berenberg Bank analyst Kerry Holford has reaffirmed a Buy rating on Novo Nordisk (0QIU) with a price target of DKK360.00 | [Link](https://longbridge.com/en/news/275719942.md) | | Novo Nordisk to Manufacture Wegovy in Ireland Facility | Novo Nordisk to Manufacture Wegovy in Ireland Facility | [Link](https://longbridge.com/en/news/275789396.md) | | Savvy Advisors Inc. Purchases 22,138 Shares of Novo Nordisk A/S $NVO | Savvy Advisors Inc. increased its stake in Novo Nordisk A/S by 83.0% in Q3, acquiring 22,138 shares, bringing its total | [Link](https://longbridge.com/en/news/275761183.md) | | Novo Nordisk Aims To Start Selling Its Weight-Loss Blockbuster Wegovy In Vials - Bloomberg News | NOVO NORDISK AIMS TO START SELLING ITS WEIGHT-LOSS BLOCKBUSTER WEGOVY IN VIALS - BLOOMBERG NEWS | [Link](https://longbridge.com/en/news/275654518.md) | --- > **Disclaimer**: This article is for reference only and does not constitute any investment advice.